Ware, United Kingdom

Torquil I Jack


Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Bishops Stortford, GB (1994)
  • Ware, GB (1993 - 1996)

Company Filing History:


Years Active: 1993-1996

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Torquil I Jack: Innovator in Benzofuran Derivatives

Introduction

Torquil I Jack is a notable inventor based in Ware, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of benzofuran derivatives. With a total of 5 patents to his name, his work has implications for treating hypertension and cognitive disorders.

Latest Patents

Jack's latest patents focus on benzofuran derivatives. The first patent provides compounds of formula (I) or a physiologically acceptable salt, solvate, or metabolically labile ester thereof, wherein the R groups are defined in the specification. These compounds may be utilized in the treatment or prophylaxis of hypertension and diseases associated with cognitive disorders. The second patent also involves compounds of the general formula (I) and physiologically acceptable salts, solvates, or non-toxic metabolically labile esters thereof, where R¹ represents a halogen atom, and Ar represents a specific group. This innovation further explores the potential of benzofuran derivatives in medical applications.

Career Highlights

Torquil I Jack has established himself as a key figure in the pharmaceutical industry. He works at Glaxo Group Limited, where he continues to innovate and develop new compounds that can lead to significant advancements in medical treatments.

Collaborations

Jack has collaborated with notable coworkers, including Barry C Ross and David Middlemiss. Their combined expertise has contributed to the successful development of various pharmaceutical innovations.

Conclusion

Torquil I Jack's work in the field of benzofuran derivatives showcases his commitment to advancing medical science. His patents reflect a dedication to improving treatment options for hypertension and cognitive disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…